Male/Female |
22/16 |
21/11 |
0.6243
|
Age, year |
55.8±9.9 |
55.5±9.1 |
0.9101
|
BMI, kg/m2
|
28.1±4.1 |
28.1±4.3 |
0.9671
|
SBP, mmHg |
130 (100-170) |
125 (110-170) |
0.1832
|
DBP, mmHg |
80 (60-100) |
77.5 (60-100) |
0.0752
|
ACEI/ARB |
21/17 |
21/11 |
0.3783
|
DM duration, year |
11.5(1-30) |
3(0-25) |
<0.0012
|
Retinopathy, y/n |
28/10 |
0/32 |
<0.0013
|
Neuropathy, y/n |
22/16 |
1/31 |
<0.0013
|
CAD, y/n |
14/24 |
3/29 |
0.0083
|
Heart Failure, y/n |
7/31 |
0/32 |
0.0134
|
HT, y/n |
35/3 |
23/9 |
0.0253
|
Insulin, y/n |
26/12 |
11/21 |
0.0043
|
eGFR<90 ml/min/1.73m2, y/n |
33/5 |
17/15 |
<0.0023
|
eGFR<60 ml/min/1.73m2, y/n |
29/9 |
9/23 |
<0.0013
|
eGFR<30 ml/min/1.73m2, y/n |
18/20 |
2/30 |
<0.0013
|
eGFR_0th month, ml/min/1.73m2
|
37.5(10-116) |
88.5(11-127) |
<0.0012
|
eGFR_6th month, ml/min/1.73m2
|
23.5(8-108) |
90.5
(14-132) |
<0.0012
|
eGFR_12th month,ml/min/1.73m2
|
15 (6-105) |
89.5(15-141) |
<0.0012
|
Creatinine, mg/dl |
2.02 (0.62-4.63) |
0.92(0.41-5.14) |
<0.0012
|
Hb, gr/dl |
10.8±1.87 |
13.3±2.0 |
<0.0011
|
Glucose, mg/dl |
152 (60-427) |
135(89-290) |
0.1502
|
HbA1C, % |
7.5 (5.5-13.7) |
6.9 (5.5-11) |
0.0992
|
T.protein, gr/dl |
5.69±0.93 |
5.00±1.21 |
0.0111
|
Albumin, gr/dl |
2.62±0.63 |
2.44±1.04 |
0.4081
|
Proteinuria_0. month mg/d |
9841±6052 |
8778±4804 |
0.4251
|
Proteinuria_6. month, mg/d |
6662(874-19467) |
3350 (207-13221) |
0.0032
|
Proteinuria_12. month, mg/d |
10663(750-20500) |
1342(102-11575) |
<0.0012
|
Proteinuria >10 gr/d, y/n |
19/19 |
13/19 |
0.4333
|
Na, mmol/l |
136.4±3.1 |
137.9±3.8 |
0.0611
|
Ca, mg/dl |
8.39±0.68 |
8.49±0.78 |
0.5631
|
T. Cholesterol, mg/dl |
249±89 |
289±82 |
0.0581
|
Triglycerides, mg/dl |
203(58-665) |
229(91-662) |
0.3082
|
LDL, mg/dl |
162±71 |
191±70 |
0.0881
|
Kidney biopsy
Sclerosis glomeruli count Interstitial fibrosis,%
Basal membrane thickening
Mesangial matrix increase
Tubular atrophy
|
3 (0-16)
10(0-50)
37/1
34/4
36/2
|
1 (0-7)
3 (0-20)
23/9
13/19
20/12
|
0.0012
<0.0012
0.0043
<0.0013
0.0013
|